Which of the following represents an appropriate dosing regimen for using ondansetron (Zofran)?
a. Administer 4–8 mg IV/PO.
b. Administer 4–8 mg IV/SQ.
c. Administer 4–8 mg SQ/IM.
d. Administer only by intravenous route as ordered.
a
Rationale: a. Correct.
b. Zofran is not indicated for subcutaneous injection.
c. Zofran is not indicated for subcutaneous or intramuscular use.
d. Although it may be given intravenously, it may also be administered orally making answer "a" more appropriate.
You might also like to view...
Legislation concerning the hearing-impaired is found in which Act?
A) HIPAA B) OSHA C) ADA D) CLIA
Which of the following is true concerning the use of chemotherapeutic drugs?
a. Affects only neoplastic cells in cell cycle b. Dosage limited by the effect on normal bone marrow cells c. Affects only neoplastic cells d. Dosage limited by the effect on neoplastic cells
Which of the following is a mistake or error that jeopardizes patient safety?
A. Hospital workers not washing their hands properly B. Giving a patient the wrong dose of a drug C. Marking the wrong site for surgery D. Misidentifying a patient E. All of the above
Walking
What will be an ideal response?